Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 3
2018 4
2019 3
2020 5
2021 3
2022 11
2023 14
2024 10
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
When to Start, When to Stop With Colorectal Cancer Screening: A Cost-Effectiveness Analysis.
van de Schootbrugge-Vandermeer HJ, Toes-Zoutendijk E, de Jonge L, van Leerdam ME, Lansdorp-Vogelaar I. van de Schootbrugge-Vandermeer HJ, et al. Among authors: toes zoutendijk e. Gastroenterology. 2024 Sep;167(4):801-803.e5. doi: 10.1053/j.gastro.2024.05.007. Epub 2024 May 16. Gastroenterology. 2024. PMID: 38762073 Free article. No abstract available.
Cancer screening programs in South-east Asia and Western Pacific.
Wee HL, Canfell K, Chiu HM, Choi KS, Cox B, Bhoo-Pathy N, Simms KT, Hamashima C, Shen Q, Chua B, Siwaporn N, Toes-Zoutendijk E. Wee HL, et al. Among authors: toes zoutendijk e. BMC Health Serv Res. 2024 Jan 18;24(1):102. doi: 10.1186/s12913-023-10327-8. BMC Health Serv Res. 2024. PMID: 38238704 Free PMC article. Review.
Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers.
van der Schee L, Haasnoot KJC, Elias SG, Gijsbers KM, Alderlieste YA, Backes Y, van Berkel AM, Boersma F, Ter Borg F, Breekveldt ECH, Kessels K, Koopman M, Lansdorp-Vogelaar I, van Leerdam ME, Rasschaert G, Schreuder RM, Schrauwen RWM, Seerden TCJ, Spanier MBW, Terhaar Sive Droste JS, Toes-Zoutendijk E, Tuynman JB, Vink GR, de Vos Tot Nederveen Cappel WH, Vleggaar FP, Laclé MM, Moons LMG. van der Schee L, et al. Among authors: toes zoutendijk e. Endoscopy. 2024 Jul;56(7):484-493. doi: 10.1055/a-2263-2841. Epub 2024 Feb 7. Endoscopy. 2024. PMID: 38325403 Free PMC article.
Response to Larsen et al.
van de Schootbrugge-Vandermeer HJ, Kooyker A, Toes-Zoutendijk E, Spaander MCW, van Leerdam ME. van de Schootbrugge-Vandermeer HJ, et al. Among authors: toes zoutendijk e. Endoscopy. 2024 Aug;56(8):635-636. doi: 10.1055/a-2292-9126. Epub 2024 Jul 30. Endoscopy. 2024. PMID: 39079527 No abstract available.
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.
van de Schootbrugge-Vandermeer HJ, Kooyker AI, Wisse PHA, Nagtegaal ID, Geuzinge HA, Toes-Zoutendijk E, de Jonge L, Breekveldt ECH, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Lansdorp-Vogelaar I, Spaander MCW, van Leerdam ME. van de Schootbrugge-Vandermeer HJ, et al. Among authors: toes zoutendijk e. Endoscopy. 2023 Dec;55(12):1061-1069. doi: 10.1055/a-2136-6564. Epub 2023 Oct 4. Endoscopy. 2023. PMID: 37793423 Free PMC article.
Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett's Neoplasia.
van Munster SN, Verheij EPD, Ozdemir Ö, Toes-Zoutendijk E, Lansdorp-Vogelaar I, Nieuwenhuis EA, Cotton CC, Weusten BLAM, Alvarez Herrero L, Alkhalaf A, Schenk BE, Schoon EJ, Curvers WL, Koch AD, de Jonge PF, Tang TJ, Nagengast WB, Westerhof J, Houben MHMG, Shaheen NJ, Bergman JJGHM, Pouw RE. van Munster SN, et al. Among authors: toes zoutendijk e. Gastroenterology. 2024 Jun;166(6):1058-1068. doi: 10.1053/j.gastro.2024.02.033. Epub 2024 Mar 4. Gastroenterology. 2024. PMID: 38447738 Free article.
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening.
Kooyker A, de Jonge L, Toes-Zoutendijk E, Spaander M, van Vuuren H, Kuipers E, van Kemenade F, Ramakers C, Dekker E, Nagtegaal I, van Leerdam M, Lansdorp-Vogelaar I. Kooyker A, et al. Among authors: toes zoutendijk e. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3424-3432.e2. doi: 10.1016/j.cgh.2023.07.028. Epub 2023 Aug 22. Clin Gastroenterol Hepatol. 2023. PMID: 37619823 Free article.
Harm-to-Benefit Ratio of Fecal Immunochemical Test-Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations.
Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, Katsara MA, de Jonge L, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I, Meester RGS. Toes-Zoutendijk E, et al. Clin Gastroenterol Hepatol. 2024 Oct 11:S1542-3565(24)00878-4. doi: 10.1016/j.cgh.2024.08.041. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39395573 Free article.
42 results